Clinical Trial Update: European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma

View source ↗

Summary

This trial is investigating the use of circulating tumor DNA as a non-invasive biomarker to monitor therapy in pediatric classical Hodgkin lymphoma and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Classical Hodgkin Lymphoma | Status: RECRUITING